Myrexis Cmn Stk Stock Cash And Equivalents
| MYRXDelisted Stock | USD 0 0.00 0.00% |
Myrexis Cmn Stk fundamentals help investors to digest information that contributes to Myrexis Cmn's financial success or failures. It also enables traders to predict the movement of Myrexis Pink Sheet. The fundamental analysis module provides a way to measure Myrexis Cmn's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Myrexis Cmn pink sheet.
Myrexis |
Myrexis Cmn Stk Company Cash And Equivalents Analysis
Myrexis Cmn's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Current Myrexis Cmn Cash And Equivalents | 1.21 M |
Most of Myrexis Cmn's fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Myrexis Cmn Stk is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
CompetitionIn accordance with the recently published financial statements, Myrexis Cmn Stk has 1.21 M in Cash And Equivalents. This is 100.0% lower than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The cash and equivalents for all United States stocks is 99.96% higher than that of the company.
Myrexis Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Myrexis Cmn's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Myrexis Cmn could also be used in its relative valuation, which is a method of valuing Myrexis Cmn by comparing valuation metrics of similar companies.Myrexis Cmn is currently under evaluation in cash and equivalents category among its peers.
Myrexis Fundamentals
| Return On Equity | -0.26 | ||||
| Return On Asset | -0.15 | ||||
| Current Valuation | 3.93 M | ||||
| Shares Outstanding | 34.48 M | ||||
| Shares Owned By Institutions | 1.25 % | ||||
| Number Of Shares Shorted | 48.45 K | ||||
| Price To Earning | (0.10) X | ||||
| Price To Book | 4.42 X | ||||
| EBITDA | (10.8 M) | ||||
| Net Income | (11.62 M) | ||||
| Cash And Equivalents | 1.21 M | ||||
| Cash Per Share | 0.04 X | ||||
| Debt To Equity | (1.51) % | ||||
| Current Ratio | 16.72 X | ||||
| Book Value Per Share | 0.03 X | ||||
| Cash Flow From Operations | (12.97 M) | ||||
| Short Ratio | 0.39 X | ||||
| Earnings Per Share | (0.39) X | ||||
| Target Price | 5.0 | ||||
| Beta | 2.49 | ||||
| Market Capitalization | 4.14 M | ||||
| Total Asset | 1.24 M | ||||
| Retained Earnings | (128.49 M) | ||||
| Working Capital | 1.16 M | ||||
| Current Asset | 1.24 M | ||||
| Current Liabilities | 74 K | ||||
| Net Asset | 1.24 M |
About Myrexis Cmn Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Myrexis Cmn Stk's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Myrexis Cmn using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Myrexis Cmn Stk based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Consideration for investing in Myrexis Pink Sheet
If you are still planning to invest in Myrexis Cmn Stk check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Myrexis Cmn's history and understand the potential risks before investing.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |